DAVITA HEALTHCARE PARTNERS INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(continued)

(dollars in thousands, except per share data)

29.	Supplemental data (unaudited)

The following information is presented as supplemental data as required by the indentures governing the Company’s Senior Notes.

Condensed Consolidating Statements of Income

	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2015
Patient services revenues	$	9,480,279		$	133,036		$	—		$	9,347,243
Less: Provision for uncollectible accounts		(427,860	)		(7,937	)		—			(419,923	)
Net patient service revenues		9,052,419			125,099			—			8,927,320
Capitated revenues		3,509,095			1,649,176			—			1,859,919
Other revenues		1,220,323			7,849			—			1,212,474
Total net revenues		13,781,837			1,782,124			—			11,999,713
Operating expenses and charges		12,611,142			1,700,384			(13	)		10,910,771
Operating income		1,170,695			81,740			13			1,088,942
Debt (expense) and refinancing charges		(456,452	)		(9,986	)		—			(446,466	)
Other income, net		8,893			434			—			8,459
Income tax expense		295,726			20,491			5			275,230
Net income		427,410			51,697			8			375,705
Less: Net income attributable to noncontrolling interests		(157,678	)		—			—			(157,678	)
Net income attributable to DaVita HealthCare Partners Inc.	$	269,732		$	51,697		$	8		$	218,027

Condensed Consolidating Statements of Comprehensive Income

	Consolidated Total			Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2015
Net income (losses)	$	427,410		$	51,697	$	8	$	375,705
Other comprehensive losses		(34,809	)		—		—		(34,809	)
Total comprehensive income (losses)		392,601			51,697		8		340,896
Less: Comprehensive income attributable to noncontrolling interest		(157,678	)		—		—		(157,678	)
Comprehensive income (losses) attributable to DaVita HealthCare Partners Inc.	$	234,923		$	51,697	$	8	$	183,218

(1)	After the elimination of the unrestricted subsidiaries and the physician groups

Condensed Consolidating Balance Sheets

	Consolidated Total		Physician Groups		Unrestricted Subsidiaries		Company and Restricted Subsidiaries⁽¹⁾
As of December 31, 2015
Cash and cash equivalents	$	1,499,116	$	88,245	$	—	$	1,410,871
Accounts receivable, net		1,724,228		357,126		—		1,367,102
Other current assets		1,279,936		15,714		—		1,264,222
Total current assets		4,503,280		461,085		—		4,042,195
Property and equipment, net		2,788,740		1,836		—		2,786,904
Amortizable intangibles, net		1,687,326		5,937		—		1,681,389
Other long-term assets		241,050		73,794		2,824		164,432
Goodwill		9,294,479		15,967		—		9,278,512
Total assets	$	18,514,875	$	558,619	$	2,824	$	17,953,432
Current liabilities	$	2,399,138	$	234,182	$	—	$	2,164,956
Payables to parent		—		206,429		2,824		(209,253	)
Long-term debt and other long-term liabilities		10,167,499		49,782		—		10,117,717
Noncontrolling interests subject to put provisions		864,066		—		—		864,066
Total DaVita HealthCare Partners Inc. shareholders'’ equity		4,870,780		68,226		—		4,802,554
Noncontrolling interests not subject to put provisions		213,392		—		—		213,392
Shareholders' equity		5,084,172		68,226		—		5,015,946
Total liabilities and shareholder's equity	$	18,514,875	$	558,619	$	2,824	$	17,953,432

Condensed Consolidating Statements of Cash Flows

	Consolidated Total			Physician Groups			Unrestricted Subsidiaries			Company and Restricted Subsidiaries⁽¹⁾
For the year ended December 31, 2015
Cash flows from operating activities:
Net income	$	427,410		$	51,697		$	8		$	375,705
Changes in operating and intercompany assets and liabilities and non-cash items included in net income		1,129,790			(101,217	)		(8	)		1,231,015
Net cash provided by operating activities		1,557,200			(49,520	)		—			1,606,720
Cash flows from investing activities:
Additions of property and equipment		(707,998	)		(355	)		—			(707,643	)
Acquisitions and divestitures, net		(96,469	)		—			—			(96,469	)
Proceeds from asset sales		19,715			—			—			19,715
Investments and other items		(97,032	)		(3,124	)		—			(93,908	)
Net cash used in investing activities		(881,784	)		(3,479	)		—			(878,305	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		619,698			—			—			619,698
Intercompany		—			28,796			—			(28,796	)
Other items		(758,668	)		—			—			(758,668	)
Net cash used in financing activities		(138,970	)		28,796			—			(167,766	)
Effect of exchange rate changes on cash		(2,571	)		—			—			(2,571	)
Net increase (decrease) in cash		533,875			(24,203	)		—			558,078
Cash at beginning of the year		965,241			112,448			—			852,793
Cash at the end of the year	$	1,499,116		$	88,245		$	—		$	1,410,871

(1)	After the elimination of the unrestricted subsidiaries and the physician groups

F-1